Nesina Tablets 25mg, manufactured by Teijin Pharma, contain Alogliptin benzoate, a DPP-4 inhibitor indicated for the treatment of type 2 diabetes mellitus to improve glycemic control. It is available as a 25mg 1 tablet with YJ code 3969012F3028.
Nesina Tablets 25mg
Need more detailed information?
Contact TASAKI PHARMA for inquiries about this medicine (English support available).
Contact us about this drug →
